VESO (Veterinærmedisinsk Oppdragssenter AS) was established by the Norwegian Agricultural Science Council in 1988 and later transformed into a limited company in 1991 under the Ministry of Agriculture and Food. VESO was privatized in the period 2008 to 2010 through an MBO (Management Buy out). The state completely sold out in 2019 and VESO is today 95% owned by AquaNova Invest AS. The remaining shares are owned by current and former employees.
VESO was privatized in the period 2008 to 2010 through an MBO (Management Buy out). The state completely sold out in 2019 and VESO is today 95% owned by AquaNova Invest AS. The remaining shares are owned by current and former employees. Since privatization, VESO has grown more than 8 times in turnover (average annual growth of more than 14%) as a result of increased market shares and growth in the fishing and animal health market in Norway, investment in new businesses, establishment in new markets and launch of new products and services.
In 2007 VESO established, in collaboration with Akvaforsk (Currently NOFIMA) and Sintef, AVS Chile. VESO took over 100% of the company in 2017. Since the takeover, VESO Chile has experienced strong growth and is today a leading supplier to the Chilean farming industry
VESO invested significant resources in developing a breeding and genetics business from 2007. In 2015, we sold this business to Benchmark Holding, which had the financial muscle to further develop this business.
In 2018, VESO established a Contract research facility in Chile through a collaboration with Cargill (EWOS)
In 2016, VESO took over 51% of Brynsløkken AS, which develops and produces antifouling and other chemical products. Since then, the company has experienced strong growth and development and is today one of the leading suppliers in this market.
In 2022, we established VESO ehf in Iceland in collaboration with an experienced Icelandic founding team. The company is well positioned to take its share of the expected growth in the Icelandic aquaculture market.
In recent years, we have expanded our product portfolio in the animal and fish health market beyond vaccines and pharmaceuticals. By collaborating with innovative developers and leading international manufacturers, we have launched or taken over agencies for hygiene products, veterinary consumables, dietary supplements and microbial products.